FindTrial
Sign In

Effect of adjuvant yoga therapy on cardiorespiratory morbidity in COVID

Effect of Adjuvant Yoga therapy on Long Term Cardiorespiratory Morbidity and Altered Serum Inflammatory Markers in COVID Recovered Patients - A Randomized Control Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/10/037605
Enrollment
142
Registered
2021-10-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Adjuvant Yoga therapy: 6 sessions will be given per weeks (3 observed and 3 non observed sessions / week) for 8 weeks duration. Control Intervention1: Nil: Nil

Sponsors

Aarupadi Veedu medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: COVID recovered patients of age group 18 â?? 45 years, after 3 months of initial infection, with negative RT PCR results will be recruited into the study.

Exclusion criteria

Exclusion criteria: • Hypertension • Diabetes Mellitus • Other endocrine and metabolic disorders • On medications that affect autonomic nervous system • Pregnancy and lactation

Design outcomes

Primary

MeasureTime frame
Effect of pranayma on cardiorespiratory morbidity and inflmmation in COVID recovered patientsTimepoint: Baseline, 4 weeks and 8 weeks—

Secondary

MeasureTime frame
prevalance of caridiorespiratory morbidity in covid recovered patientsTimepoint: baseline—

Countries

India

Contacts

Public ContactDr Jothi Marie Feula A

Aarupadai Veedu Medical College and Hospital, VMRF (Deemed to be university)

dr.feula@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026